Alkunani AS, Shareef LG, Al Arajy AZ. Claudin-6 (CLDN6) and Folate Receptor Alpha (FRα) Targeted Antibody-Drug Conjugates: Bypassing Platinum Resistance and Tumor Heterogeneity in High-Grade Serous Ovarian Carcinoma. Al-Rafidain J Med Sci [Internet]. 2026 Oct. 19 [cited 2026 Oct. 19];11(2):140-51. Available from: https://ajms.iq/index.php/ALRAFIDAIN/article/view/3258